Trial intelligence / Profile preview

Calcitriol for Cocaine Use Disorder

NCT04826133Phase 1Terminated

Sponsor
Yale University
Start
Mar 2019
Primary completion
Jan 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in cocaine use disorder (CUD) comparing Calcitriol Arm with Placebo Arm (2 arms). Primary endpoints: Cocaine Self Administration Attempts at 90 minutes and Cocaine Self Administration Infusions at 90 minutes. Started Mar 2019; status: terminated.

02

Drugs

calcitriol
03

Conditions

cocaine use disorder (CUD)

Beyond the preview

Go deeper on NCT04826133.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04826133.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call